ASPIRE update: Carfilzomib triplet for relapsed / refractory myeloma

Bookmark and Share
Published: 10 Dec 2017
Views: 2026
Rating:
Save
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA

Prof Stewart speaks with ecancer at the 2017 ASH annual meeting about updated data from the ASPIRE study looking at the use of carfilzomib in multiple myeloma.

Prof Stewart spoke with ecancer about the ASPIRE study at the 2014 ASH annual meeting.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.